Given these considerations, there is an urgent need for an updated meta-analysis to achieve the following objectives: (1) to synthesize the evidence regarding the efficacy of Tα1 in patients with sepsis overall, and (2) to evaluate the comparative efficacy of Tα1 across various subgroups of septic patients. This evidence concerns the gene TAAR1 and Sepsis.